Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)

Simple item page
dc.contributor.authorOrdovas, Karen G
dc.contributor.authorBaldassarre, Lauren A
dc.contributor.authorBucciarelli-Ducci, Chiara
dc.contributor.authorCarr, James
dc.contributor.authorFernandes, Juliano L
dc.contributor.authorFerreira, Vanessa M
dc.contributor.authorFrank, Luba
dc.contributor.authorMavrogeni, Sophie
dc.contributor.authorNtusi, Ntobeko
dc.contributor.authorOstenfeld, Ellen
dc.contributor.authorParwani, Purvi
dc.contributor.authorPepe, Alessia
dc.contributor.authorRaman, Subha V
dc.contributor.authorSakuma, Hajime
dc.contributor.authorSchulz-Menger, Jeanette
dc.contributor.authorSierra-Galan, Lilia M
dc.contributor.authorValente, Anne M
dc.contributor.authorSrichai, Monvadi B
dc.date.accessioned2021-05-20T10:20:52Z
dc.date.available2021-05-20T10:20:52Z
dc.date.issued2021-05-10
dc.date.updated2021-05-16T03:10:09Z
dc.description.abstractAbstract This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR.
dc.identifier.citationJournal of Cardiovascular Magnetic Resonance. 2021 May 10;23(1):52
dc.identifier.ris TY - AU - Ordovas, Karen G AU - Baldassarre, Lauren A AU - Bucciarelli-Ducci, Chiara AU - Carr, James AU - Fernandes, Juliano L AU - Ferreira, Vanessa M AU - Frank, Luba AU - Mavrogeni, Sophie AU - Ntusi, Ntobeko AU - Ostenfeld, Ellen AU - Parwani, Purvi AU - Pepe, Alessia AU - Raman, Subha V AU - Sakuma, Hajime AU - Schulz-Menger, Jeanette AU - Sierra-Galan, Lilia M AU - Valente, Anne M AU - Srichai, Monvadi B AB - Abstract This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR. DA - 2021-05-10 DB - OpenUCT DP - University of Cape Town KW - Cardiovascular magnetic resonance KW - Women KW - Cardiovascular disease KW - Society for Cardiovascular Magnetic Resonance KW - Position statement LK - https://open.uct.ac.za PY - 2021 T1 - Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) TI - Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) UR - http://hdl.handle.net/11427/33240 ER - en_ZA
dc.identifier.urihttps://doi.org/10.1186/s12968-021-00746-z
dc.identifier.urihttp://hdl.handle.net/11427/33240
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.source.journalvolume23
dc.source.urihttps://jcmr-online.biomedcentral.com/
dc.subjectCardiovascular magnetic resonance
dc.subjectWomen
dc.subjectCardiovascular disease
dc.subjectSociety for Cardiovascular Magnetic Resonance
dc.subjectPosition statement
dc.titleCardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
12968_2021_Article_746.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles